Publications by authors named "Raminder Aul"

Claim this Profile
D
Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications.
Tejaswini Kulkarni, Joel Santiaguel, Raminder Aul, Mark Harnett, Julie Krop

ERJ Open Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.
Olivia C Leavy, Richard J Russell, Ewen M Harrison, Nazir I Lone, Steven Kerr, Hamish J C McAuley, Raminder Aul, Paul Beirne, Paul Pfeffer

ERJ Open Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.
Omer Elneima, Hamish J C McAuley, Olivia C Leavy, James D Chalmers, Alex Horsley, Raminder Aul, Paul Beirne, Paul Pfeffer

Int J Epidemiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Callum Jackson, Iain D Stewart, Tatiana Plekhanova, Peter S Cunningham, Andrew L Hazel, Raminder Aul, Hamish J C McAuley

Lancet Respir Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of high-intensity interval training versus moderate-intensity continuous training in pulmonary rehabilitation for interstitial lung disease: a randomised controlled pilot feasibility trial.
Dimitra Nikoletou, Irina Chis Ster, Carmen Y Lech, Iain S MacNaughton, Felix Chua, Raminder Aul, Paul W Jones

BMJ Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
Jim M Wild, Joanna C Porter, Philip L Molyneaux, Peter M George, Iain Stewart, Raminder Aul, Paul Beirne

BMJ Open Respir Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceleration of interstitial lung disease induced by raltitrexed.
Sarah Howlett, Raminder Aul, Mark Hill, David J Pinato

J Oncol Pharm Pract· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reproducibility of bolus allergen challenges; power calculations for clinical trials.
Raminder Aul, Hayley King, Umme Kolsum, Dave Singh

Eur J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects.
Raminder Aul, Jane Armstrong, Annelyse Duvoix, David Lomas, Brian Hayes

Br J Clin Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
Raminder Aul, Sheena Patel, Susan Summerhill, Iain Kilty, Jonathan Plumb

Int Immunopharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis